KEGG   PATHWAY: cgib03320
Entry
cgib03320                   Pathway                                
Name
PPAR signaling pathway - Carassius gibelio (silver crucian carp)
Description
Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that are activated by fatty acids and their derivatives. PPAR has three subtypes (PPARalpha, beta/delta, and gamma) showing different expression patterns in vertebrates. Each of them is encoded in a separate gene and binds fatty acids and eicosanoids. PPARalpha plays a role in the clearance of circulating or cellular lipids via the regulation of gene expression involved in lipid metabolism in liver and skeletal muscle. PPARbeta/delta is involved in lipid oxidation and cell proliferation. PPARgamma promotes adipocyte differentiation to enhance blood glucose uptake.
Class
Organismal Systems; Endocrine system
Pathway map
cgib03320  PPAR signaling pathway
cgib03320

Organism
Carassius gibelio (silver crucian carp) [GN:cgib]
Gene
127934005  [KO:K08765] [EC:2.3.1.21]
127934185  [KO:K00255] [EC:1.3.8.8]
127934621  zgc:158482; long-chain fatty acid transport protein 2 [KO:K08746] [EC:6.2.1.- 6.2.1.3]
127935224  [KO:K01897] [EC:6.2.1.3]
127935741  [KO:K08525]
127935922  [KO:K08752]
127935933  [KO:K08752]
127938078  [KO:K08756]
127938879  [KO:K08526]
127941422  [KO:K01897] [EC:6.2.1.3]
127941531  [KO:K08755]
127941792  [KO:K08524]
127943073  [KO:K04504]
127943264  [KO:K01059] [EC:3.1.1.34]
127945923  [KO:K08765] [EC:2.3.1.21]
127945931  [KO:K06276] [EC:2.7.11.1]
127946541  [KO:K01596] [EC:4.1.1.32]
127946603  [KO:K07513] [EC:2.3.1.16]
127946710  [KO:K08765] [EC:2.3.1.21]
127946827  [KO:K08746] [EC:6.2.1.- 6.2.1.3]
127946828  [KO:K08746] [EC:6.2.1.- 6.2.1.3]
127946970  [KO:K10226] [EC:1.14.19.3]
127947225  [KO:K07294]
127947284  [KO:K15013] [EC:6.2.1.3]
127949157  [KO:K08751]
127949366  [KO:K01897] [EC:6.2.1.3]
127949649  [KO:K00864] [EC:2.7.1.30]
127949662  [KO:K08765] [EC:2.3.1.21]
127950474  [KO:K00489] [EC:1.14.14.23]
127950969  [KO:K07431] [EC:1.14.14.139]
127950996  [KO:K01897] [EC:6.2.1.3]
127951060  [KO:K08764] [EC:2.3.1.176]
127951104  [KO:K01059] [EC:3.1.1.34]
127951402  [KO:K08767]
127951502  [KO:K07296]
127951657  [KO:K08524]
127951660  [KO:K00249] [EC:1.3.8.7]
127952255  [KO:K08751]
127952379  [KO:K06276] [EC:2.7.11.1]
127953250  [KO:K06276] [EC:2.7.11.1]
127953582  [KO:K08745] [EC:6.2.1.-]
127956719  [KO:K06259]
127957057  [KO:K08524]
127957526  [KO:K01897] [EC:6.2.1.3]
127957979  [KO:K08770]
127958759  [KO:K15013] [EC:6.2.1.3]
127958906  [KO:K08750]
127959978  si:ch211-113j14.1; sterol 26-hydroxylase, mitochondrial [KO:K00488] [EC:1.14.15.15]
127960279  [KO:K08761]
127961200  [KO:K00489] [EC:1.14.14.23]
127961859  [KO:K08765] [EC:2.3.1.21]
127961992  [KO:K08536]
127962094  [KO:K00232] [EC:1.3.3.6]
127962930  [KO:K08750]
127963428  [KO:K04504]
127963906  [KO:K15013] [EC:6.2.1.3]
127963924  [KO:K08766] [EC:2.3.1.21]
127964365  [KO:K00029] [EC:1.1.1.40]
127964813  [KO:K00488] [EC:1.14.15.15]
127965099  [KO:K08762]
127965244  [KO:K07514] [EC:4.2.1.17 1.1.1.35 5.3.3.8]
127965339  [KO:K00488] [EC:1.14.15.15]
127965811  [KO:K08770]
127966362  [KO:K08745] [EC:6.2.1.-]
127966589  [KO:K01897] [EC:6.2.1.3]
127966624  [KO:K06272] [EC:2.7.11.1]
127966717  [KO:K01641] [EC:2.3.3.10]
127968264  [KO:K08530]
127968879  [KO:K01897] [EC:6.2.1.3]
127968884  [KO:K00507] [EC:1.14.19.1]
127969627  [KO:K08753]
127969818  [KO:K00507] [EC:1.14.19.1]
127970060  [KO:K06086]
127970435  [KO:K08753]
127971397  [KO:K01897] [EC:6.2.1.3]
127971581  [KO:K01897] [EC:6.2.1.3]
127972351  [KO:K17284]
127972835  [KO:K08757]
127972953  [KO:K01897] [EC:6.2.1.3]
127973008  [KO:K06259]
127974442  [KO:K08758]
127974443  [KO:K08758]
127974460  [KO:K07294]
127975146  [KO:K08753]
127975419  [KO:K00029] [EC:1.1.1.40]
127976143  [KO:K08756]
127977169  [KO:K08768]
127977182  [KO:K08746] [EC:6.2.1.- 6.2.1.3]
127977595  [KO:K08765] [EC:2.3.1.21]
127977733  [KO:K00255] [EC:1.3.8.8]
127978832  [KO:K08752]
127978908  [KO:K08525]
127979576  [KO:K08752]
127983898  [KO:K08526]
127984314  [KO:K08756]
127985781  [KO:K08771]
127985863  [KO:K08524]
127985953  [KO:K01897] [EC:6.2.1.3]
127986564  [KO:K08755]
127987682  [KO:K04504]
127987964  [KO:K01059] [EC:3.1.1.34]
127988557  [KO:K01059] [EC:3.1.1.34]
127996973  [KO:K08524]
127998171  [KO:K15013] [EC:6.2.1.3]
128000895  [KO:K08770]
128003950  [KO:K08757]
128012956  [KO:K07296]
128013009  [KO:K01596] [EC:4.1.1.32]
128013202  [KO:K08765] [EC:2.3.1.21]
128013271  [KO:K06276] [EC:2.7.11.1]
128013958  [KO:K08746] [EC:6.2.1.- 6.2.1.3]
128013959  [KO:K08746] [EC:6.2.1.- 6.2.1.3]
128014141  [KO:K10226] [EC:1.14.19.3]
128014146  [KO:K07294]
128014321  [KO:K08765] [EC:2.3.1.21]
128015315  [KO:K00864] [EC:2.7.1.30]
128016026  [KO:K08761]
128016087  [KO:K01596] [EC:4.1.1.32]
128016157  [KO:K00488] [EC:1.14.15.15]
128016218  [KO:K00232] [EC:1.3.3.6]
128016617  [KO:K08765] [EC:2.3.1.21]
128016624  [KO:K08765] [EC:2.3.1.21]
128016889  [KO:K08536]
128018078  [KO:K08750]
128018257  [KO:K01897] [EC:6.2.1.3]
128018676  [KO:K04504]
128018740  [KO:K08766] [EC:2.3.1.21]
128018763  [KO:K15013] [EC:6.2.1.3]
128019558  [KO:K08762]
128019738  [KO:K00488] [EC:1.14.15.15]
128019966  [KO:K00029] [EC:1.1.1.40]
128020024  [KO:K00488] [EC:1.14.15.15]
128020768  [KO:K08770]
128021203  [KO:K06272] [EC:2.7.11.1]
128021437  [KO:K01641] [EC:2.3.3.10]
128021536  [KO:K08745] [EC:6.2.1.-]
128021569  [KO:K08749]
128021570  [KO:K08749]
128022687  [KO:K08530]
128024980  [KO:K07431] [EC:1.14.14.139]
128024994  [KO:K07431] [EC:1.14.14.139]
128025376  [KO:K01897] [EC:6.2.1.3]
128025567  [KO:K00507] [EC:1.14.19.1]
128025762  [KO:K08745] [EC:6.2.1.-]
128026249  [KO:K06086]
128026329  [KO:K00507] [EC:1.14.19.1]
128027302  [KO:K01897] [EC:6.2.1.3]
128027352  [KO:K08524]
128027710  [KO:K01897] [EC:6.2.1.3]
128027733  [KO:K00489] [EC:1.14.14.23]
128028579  [KO:K01897] [EC:6.2.1.3]
128028740  [KO:K08767]
128029104  [KO:K00249] [EC:1.3.8.7]
128029329  [KO:K17284]
128029990  [KO:K08753]
128030535  [KO:K00029] [EC:1.1.1.40]
128031203  [KO:K08758]
128031204  [KO:K08758]
128031516  [KO:K08756]
Compound
C02165  Leukotriene B4
C14762  13(S)-HODE
C14767  9(S)-HODE
C14776  8(S)-HETE
C15493  9-cis-Retinoic acid
Reference
  Authors
Takahashi N, Goto T, Kusudo T, Moriyama T, Kawada T.
  Title
[The structures and functions of peroxisome proliferator-activated receptors (PPARs)]
  Journal
Nippon Rinsho 63:557-64 (2005)
Reference
  Authors
Fujii H.
  Title
[PPARs-mediated intracellular signal transduction]
  Journal
Nippon Rinsho 63:565-71 (2005)
Reference
  Authors
Takada I, Kato S.
  Title
[PPARs target genes]
  Journal
Nippon Rinsho 63:573-7 (2005)
Reference
  Authors
Inoue H.
  Title
[Endogenous ligands for PPARs]
  Journal
Nippon Rinsho 63:578-83 (2005)
Reference
  Authors
Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W.
  Title
From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
  Journal
Prog Lipid Res 45:120-59 (2006)
DOI:10.1016/j.plipres.2005.12.002
Reference
  Authors
Desvergne B, Michalik L, Wahli W.
  Title
Transcriptional regulation of metabolism.
  Journal
Physiol Rev 86:465-514 (2006)
DOI:10.1152/physrev.00025.2005
Reference
  Authors
Mandard S, Muller M, Kersten S.
  Title
Peroxisome proliferator-activated receptor alpha target genes.
  Journal
Cell Mol Life Sci 61:393-416 (2004)
DOI:10.1007/s00018-003-3216-3
Reference
  Authors
Desvergne B, Wahli W.
  Title
Peroxisome proliferator-activated receptors: nuclear control of metabolism.
  Journal
Endocr Rev 20:649-88 (1999)
DOI:10.1210/edrv.20.5.0380
Reference
  Authors
Savage DB.
  Title
PPARgamma as a metabolic regulator: insights from genomics and pharmacology.
  Journal
Expert Rev Mol Med 2005:1-16 (2005)
DOI:10.1017/S1462399405008793
Reference
  Authors
Semple RK, Chatterjee VK, O'Rahilly S.
  Title
PPAR gamma and human metabolic disease.
  Journal
J Clin Invest 116:581-9 (2006)
DOI:10.1172/JCI28003
Reference
  Authors
Lehrke M, Lazar MA.
  Title
The many faces of PPARgamma.
  Journal
Cell 123:993-9 (2005)
DOI:10.1016/j.cell.2005.11.026
Reference
  Authors
Hauner H.
  Title
The mode of action of thiazolidinediones.
  Journal
Diabetes Metab Res Rev 18 Suppl 2:S10-5 (2002)
DOI:10.1002/dmrr.249
Related
pathway
cgib00071  Fatty acid degradation
cgib00120  Primary bile acid biosynthesis
cgib00564  Glycerophospholipid metabolism
cgib04920  Adipocytokine signaling pathway
KO pathway
ko03320   

DBGET integrated database retrieval system